Navigation Links
SpectraScience Receives Final European Certification
Date:10/10/2007

parties of the risks and factors that may affect SpectraScience's business. These forward-looking statements are qualified in their entirety by the cautions and risk factors filed by SpectraScience in its annual report on Form 10-KSB and other documents.

For further information contact Jim Hitchin at (858) 847-0200. http://www.spectrascience.com


'/>"/>
SOURCE SpectraScience, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Infant receives first bloodless liver transplant
2. British MPs Say Prostate Cancer Receives Low Priority in the NHS
3. Fifth US Patient Receives Artificial Heart
4. Northfield Labs Receives FDA Comments
5. Abbott Receives CE Mark Certification
6. Zactima Receives Fast Track Designation By The FDA
7. East London Receives World Class New Private Hospital Facility
8. Brinda Karat Receives Legal Notice over Ramdev Issue
9. Quake-Hit Pakistan Receives 30 Field Hospitals From Cuba
10. Medtronic’s Insulin Pump Receives Regulatory Approva
11. Aurobindo Receives Approval from USFDA for anti-AIDS drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... ... , ... The CRISPR-Cas9 system introduces double-strand DNA breaks at a ... either a chimeric single guide RNA (sgRNA) or two short RNAs (a CRISPR RNA ... or crRNA) to create a break in the target DNA that causes functional protein ...
(Date:9/2/2015)... ... September 02, 2015 , ... Healthegy, a leading ... two leaders who will deliver keynote presentations at the upcoming Digital Healthcare Innovation ... Hotel in Boston. , Larry Renfro, CEO of Optum, will deliver the morning ...
(Date:9/2/2015)... Washington, DC (PRWEB) , ... September 02, 2015 , ... ... company, American Well Corp., contracted to handle the telehealth services of more than 12 ... Blue Cross and Blue Shield Plans takes a look this growing trend, interviewing executives ...
(Date:9/2/2015)... ... ... Date and time: Oct. 3, 2015, 9 a.m. to 4 p.m. ... Athyn, Pa 19009 , Cost: $50 per person; includes lunch , The Quakertown, Pa.-based ... Sam Keen based on his new book which he co-authored with his son, Gifford ...
(Date:9/2/2015)... ... 2015 , ... RxNT , an innovative software solutions ... cloud-based mobile ePrescribing application. The release of this enhanced iPhone app marks the ... in health technology, RxNT was one of the first to build an ePrescribing ...
Breaking Medicine News(10 mins):Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 2Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 3Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 4Health News:Larry Renfro, CEO of Optum and Jonathan Bush, CEO of AthenaHealth to Address Healthcare Entrepreneurs and Investors at 5th Annual Digital Healthcare Innovation Summit 2Health News:Larry Renfro, CEO of Optum and Jonathan Bush, CEO of AthenaHealth to Address Healthcare Entrepreneurs and Investors at 5th Annual Digital Healthcare Innovation Summit 3Health News:AIS Newsletter Focuses on Growing Telehealth Trend Among Blues Plans 2Health News:AIS Newsletter Focuses on Growing Telehealth Trend Among Blues Plans 3Health News:justCommunity, Inc. and Bryn Athyn Men’s Groups Present Workshop on Family Reconciliation 2Health News:RxNT Releases Enhanced ePrescribing iPhone App to Improve Prescriber Usability 2
... Inc. (Phyhealth) (Pink Sheets: PHYH), a developer of,health ... the signing of a $250,000 Note with The ... working capital to support,its general corporate regulatory and ... an additional $3,500,000 in cash, which is,designated for ...
... Approves Entry into Clinical Trials on Schedule, ... -- China,Pharma Holdings, Inc. ("China Pharma") (OTC ... generic and branded bio-pharmaceutical,products in China, announced ... been granted approval by China,s State Food ...
... Mass., Oct. 29 Boston Scientific,Corporation (NYSE: BSX ... of the U.S. armed forces and service veterans better ... Care Act of 2008 was included in the National ... law by the,President. The legislation, introduced by Representative Dave ...
... -, PITTSBURGH, Oct. 29 Mylan Inc. (NYSE: ... India-based,subsidiary in which it holds a 71.5% controlling interest, ... mg and 200 mg, with the,filing of its Abbreviated ... against Matrix within the 45-day time period provided by ...
... Irvine Pharmaceutical Services,Inc., announced today that as part ... future industry demands, the company has promoted Aryo,Nikopour to ... its staff Chief Operating Officer Greg McParland. These changes ... it gears up to launch its new,subsidiary, Avrio Biopharmaceuticals, ...
... Products, According ... from HealthLeaders-InterStudy, NASHVILLE, Tenn., Oct. 29 HealthLeaders-InterStudy, ... despite,its trend-setter reputation, California is behind the curve in ... as,insurers search for the right price for their products. ...
Cached Medicine News:Health News:Phyhealth Completes $250,000 Funding 2Health News:China Pharma Holdings, Inc. to Initiate Clinical Trials For New Antibiotic Combination 2Health News:China Pharma Holdings, Inc. to Initiate Clinical Trials For New Antibiotic Combination 3Health News:Boston Scientific Welcomes Passage of Federal Pain Care Legislation to Benefit Military Members and Veterans 2Health News:Boston Scientific Welcomes Passage of Federal Pain Care Legislation to Benefit Military Members and Veterans 3Health News:Boston Scientific Welcomes Passage of Federal Pain Care Legislation to Benefit Military Members and Veterans 4Health News:Mylan's Matrix First-to-File on Generic Version of Vfend(R) Antifungal 2Health News:Irvine Pharmaceutical Services Enhances Staff, Prepares for Innovative Expansion 2Health News:California Insurers are Behind the Curve with Consumer-Driven Health Plans 2
(Date:9/2/2015)... 2015  The report on breast cancer therapeutics: pipeline ... drugs on the basis of the molecules which are ... inner lining of milk ducts or lobules responsible for ... tumor that can spread to other cells present in ... lobules is referred as lobular carcinoma, while the other ...
(Date:9/2/2015)... The quantum dot market report analyzes the ecosystem of the ... product includes medical devices, display, and others. The others segment ... storage, QD laser, and transistor. The application segment covers the ... The report also provides the geographic view for major regions ... Europe , Asia-Pacific (APAC), and ...
(Date:9/2/2015)... NEW YORK , Sept. 2, 2015 /PRNewswire/ ... dystrophy is an X-linked disease, which generally affects ... muscle degeneration and weakness. The disease is caused ... result in the lack of production of dystrophin ... in individuals. The lack of dystrophin weakens muscle ...
Breaking Medicine Technology:Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 2Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 3Quantum Dot Market by Product , Material, Application, and Geography- Forecast up to 2020 2Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 2Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 3
... (Nasdaq: ALTH ) today announced the initiation ... multi-center dose,escalation study of the Company,s targeted chemotherapeutic ... non-Hodgkin,s lymphoma (NHL). "We are pleased to ... Cagnoni, M.D., Chief Medical Officer of Allos. "RH1 ...
... Appropriate Patient Selection Criteria for Future Field ... ... Corporation (Nasdaq: DVAX ) presented yesterday a detailed,analysis of data ... for ragweed allergic rhinitis. The,data were reported yesterday at the annual ...
Cached Medicine Technology:Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non-Hodgkin's Lymphoma 2Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non-Hodgkin's Lymphoma 3Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non-Hodgkin's Lymphoma 4Dynavax Presents New Analysis of TOLAMBA(TM) Data at ACAAI Meeting 2Dynavax Presents New Analysis of TOLAMBA(TM) Data at ACAAI Meeting 3
Full Handle Laseredge Implant Blade Knife, 5.2 mm round tip. Blade dimension: 16.5 mm x 5.2 mm x 3.8 mm x 2.4 mm....
Full Handle Laseredge Implant Blade Knife, 5.2 mm angled bevel up. Blade dimension: 16.5 mm x 5.2 mm x 4.2 mm x 1.6 mm....
Full Handle Laseredge Implant Blade Knife, 4.0 mm straight. Blade dimension: 15.2 mm x 4.0 mm x 3.0 mm x 1.6 mm....
Full Handle Laseredge Crescent Blade Knife, straight. Blade tip dimension: 12.7 mm x 2.0 mm x 3.8 mm....
Medicine Products: